Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review
Cells · 08.12.2023 · 12 (24) · 2793
DOI: 10.3390/cells12242793 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cells, online erschienen am 08.12.2023. Verfasst von Parth R Upadhyay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease and presents a major public health problem worldwide. It is characterized by a recurrent and/or chronic course of inflammatory skin lesions with intense pruritus. Its pathophysiologic features include barrier dysfunction, aberrant immune cell infiltration, and alterations in the microbiome that are associated with genetic and environmental factors. There is a complex crosstalk between these components, which is primarily mediated by cytokines. Epidermal barrier dysfunction is the hallmark of AD and is caused by the disruption of proteins and lipids responsible for establishing the skin barrier. To better define the role of cytokines in stratum corneum lipid abnormalities related to AD, we conducted a systematic review of biomedical literature in PubMed from its inception to 5 September 2023. Consistent with the dominant TH2 skewness seen in AD, type 2 cytokines were featured prominently as possessing a central role in epidermal lipid alterations in AD skin. The cytokines associated with TH1 and TH17 were also identified to affect barrier lipids. Considering the broad cytokine dysregulation observed in AD pathophysiology, understanding the role of each of these in lipid abnormalities and barrier dysfunction will help in developing therapeutics to best achieve barrier homeostasis in AD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
ORCID-Profile: Parth R Upadhyay, Lucia Seminario-Vidal
Zitieren
APA
Upadhyay, P. R., Seminario-Vidal, L., Abe, B., Ghobadi, C., & Sims, J. T. (2023). Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review. Cells, 12(24), 2793. https://doi.org/10.3390/cells12242793
Vancouver
Upadhyay PR, Seminario-Vidal L, Abe B, Ghobadi C, Sims JT. Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review. Cells. 2023;12(24):2793. doi:10.3390/cells12242793
BibTeX
@article{Upadhyay2023,
author = {Upadhyay, Parth R and Seminario-Vidal, Lucia and Abe, Brian and Ghobadi, Cyrus and Sims, Jonathan T},
title = {Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review},
journal = {Cells},
year = {2023},
volume = {12},
number = {24},
pages = {2793},
doi = {10.3390/cells12242793}
}
EUVIMED